Drug Shortage Report for BYETTA

Last updated on 2019-04-16 History
Report ID 73615
Drug Identification Number 02361817
Brand name BYETTA
Common or Proper name exenatide injection
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) EXENATIDE
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1 x 2.4 mL prefilled pen / stylo pré-rempli de 2,4 mL
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-02-05
Actual start date
Estimated end date 2019-03-11
Actual end date 2019-04-01
Shortage status Resolved
Updated date 2019-04-16
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-04-16 French Compare
v9 2019-04-16 English Compare
v8 2019-02-06 English Compare
v7 2019-01-25 French Compare
v6 2019-01-25 English Compare
v5 2019-01-25 French Compare
v4 2019-01-25 English Compare
v3 2019-01-25 French Compare
v2 2019-01-25 English Compare
v1 2019-01-25 English Compare